TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Sana Pharma Sverige AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
576
|
623
|
283 |
Financial expenses |
1
|
0
![]() |
0 |
Earnings before taxes |
13
|
0
|
14 |
EBITDA |
16
|
2
|
16 |
Total assets |
900
|
319
|
94 |
Current assets |
899
|
316
|
91 |
Current liabilities |
864
|
296
|
69 |
Equity capital |
36
|
23
|
25 |
- share capital |
5
|
4
|
5 |
Employees (average) |
4
![]() |
4
|
3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
4.0%
|
7.2%
|
26.6% |
Turnover per employee |
144
|
156
|
94 |
Profit as a percentage of turnover |
2.3%
|
0%
|
4.9% |
Return on assets (ROA) |
1.6%
|
0%
|
14.9% |
Current ratio |
104.1%
|
106.8%
|
131.9% |
Return on equity (ROE) |
36.1%
|
0%
|
56.0% |
Change turnover |
-48
|
363
|
59 |
Change turnover % |
-8%
|
140%
|
27% |
Chg. No. of employees |
0
|
1
![]() |
1 |
Chg. No. of employees % |
0%
|
33%
|
50% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.